🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

TTX-MC138

Trans Code Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs and diagnostics for treating metastatic disease. Their lead product, TTX-MC138, is aimed at metastatic cancer treatment, along with a range of other therapeutic platforms targeting cancer through innovative RNA- and CRISPR-based technologies.

Tags: CRISPR technology, RNA-based therapy, biopharmaceutical, cancer treatment, metastatic disease

Website

About | Contact | Careers | Careers | About | About

Symbol: RNAZ

Recent Price: $3.76

Industry: Biotechnology

CEO: Mr. Thomas A. Fitzgerald M.B.A.

Sector: Healthcare

Employees: 10

Address: 6 Liberty Square, Boston, MA 02109

Phone: 857-837-3099

Last updated: 2024-12-31